Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

Alexander M. Menzies*, James S. Wilmott, Martin Drummond, Serigne Lo, Megan Lyle, Matthew M. K. Chan, John F. Thompson, Alex Guminski, Matteo S. Carlino, Richard A. Scolyer, Richard F. Kefford, Georgina V. Long

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences